Retinoic acid reduces the yield of herpes simplex virus in Vero cells and alters the N-glycosylation of viral envelope proteins

Antiviral Research

Volumn 47, Issue 1, 2000, Pages 29-40

  Isaacs, Charles E ^a   Xu, Weimin ^a   Pullarkat, Raju K ^a   Kascsak, Richard ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Glycosylation; Herpes simplex virus; Retinoic acid

Indexed keywords

GLUCOSAMINE; GLYCOPEPTIDASE; MANNOSE; MONENSIN; RETINOIC ACID; TUNICAMYCIN; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HERPES SIMPLEX VIRUS; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; VERO CELL; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALS; CERCOPITHECUS AETHIOPS; GLYCOSYLATION; HERPESVIRUS 1, HUMAN; TRETINOIN; VERO CELLS; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

EID: 0033883755     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(00)00090-5     Document Type: Article

References (56)

1. Angulo A., Chandraratna A.S., LeBlanc J.F., Ghazal P. Ligand induction of retinoic acid receptors alters an acute infection by murine cytomegalovirus. J. Virol. 72:1998;4589-4600.
2. Angulo A., Suot C., Boehm M.F., Heyman R.A., Ghazal P. Retinoid activation of retinoic acid receptors but not of retinoid X receptors promotes cellular differentiation and replication of human cytomegalovirus in embryonal cells. J. Virol. 69:1995;3831-3837.
3. Bergeron J.J.M., Brenner M.G., Thomas D.Y., Williams D.B. Calnexin: a membrane-bound chaperone of the endoplasmic reticulum. Trends Biochem. Sci. 19:1994;124-128.
4. Billiau A., Hermans H., Allen P.T., Baron S., DeSomer P. Interferon inhibits C-type virus at a posttranscriptional prerelease step. Arch. Virol. 57:1978;205-220.
5. Brown Z.A., Selke S., Zeh J. et al. The acquisition of herpes simplex virus during pregnancy. New Engl. J. Med. 337:1997;509-515.
6. Campadelli-Fiume G., Poletti L., Dall'Olio F., Serafini-Cessi F. Infectivity and glycoprotein processing of herpes simplex virus type 1 grown in a ricin-resistant cell line deficient in N-acetylglucosaminyl transferase I. J. Virol. 43:1982;1061-1071.
7. Carmack M.A., Prober C.G. Neonatal herpes: vexing dilemmas and reasons for hope. Pediatrics. 5:1993;21-28.
8. Caughey B., Raymond G.J. The scrapie-associated form of PrP is made from a cell surface precursor that is both protease-and phospholipase-sensitive. J. Biol. Chem. 266:1991;18217-18223.
9. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J. 10:1996;940-954.
10. Chatterjie S., Nishimuro S., Whitley R.J. Expression of HSV-1 glycoproteins in tunicamycin-treated monkey kidney cells. Biochem. Biophys. Res. Comm. 167:1990;1139-1145.
11. Deshmane N., Pagano J.S., Liao W., Kenney S. Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection. Proc. Natl. Acad. Sci. USA. 90:1993;3894-3898.
12. Elbein A.D. Glycosidase inhibitors: inhibitors of N-linked oligosaccharide processing. FASEB J. 5:1991;3055-3063.
13. Fischer P.B, Collin M., Karlsson G.B. et al. The α-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding. J. Virol. 69:1995;5791-5797.
14. Fischer P.B., Karlsson G.B., Dwek R.A., Platt F.M. N-butyldeoxynojiri-mycin-mediated inhibition of human immunodeficiency virus entry correlated with impaired gp 120 shedding and gp 41 exposure. J. Virol. 70:1996;7153-7160.
15. Forsgren M., Malm G. Herpes simplex virus and pregnancy. Scand. J. Infect. Dis. Suppl. 100:1996;14-19.
16. Glorioso J., Szczesiul M.S., Marlin S.D., Levine M. Inhibition of herpes simplex virus glycoproteins: Identification of antigenic and immunogenic partially glycosylated glycopeptides on the cell surface membrane. Virology. 126:1983;1-18.
17. Hammond C., Helenius A. Folding of VSV G protein; sequential interaction with BiP and calnexin. Science. 266:1994;456-458.
18. Hansen B.D., Nara P.L., Maheshwari R.K., Sidhu G.S., Bernbaum J.B., Hoekzema D., Meltzer M.S., Gendelman H.E. Loss of infectivity by progeny virus from alpha interferon-treated human immunodeficiency virus type 1-infected T cells is associated with defective assembly of envelope gp 120. J. Virol. 66:1992;7543-7548.
19. Herold B.C., Dunn D.W., Soltys N., Spear P.G. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J. Virol. 65:1991;1090-1098.
20. Hsu S.-L., Lin Y.-F., Chou C.-K. Retinoic acid biphasically regulates the gene expression of hepatitis B virus surface antigen in human hepatoma Hep3B cells. J. Biol. Chem. 268:1993;23093-23097.
21. Huan B., Siddiqui A. Retinoid X receptor RARα binds to and trans-activates the hepatitis B virus enhancer. Proc. Natl. Acad. Sci. USA. 89:1992;9059-9063.
22. Isaacs C.E., Kascsak R., Pullarkat R.K., Xu W., Schneidman K. Inhibition of herpes simplex virus replication by retinoic acid. Antiv. Res. 33:1997;117-127.
23. Johnson D.C., Ligas M.W. Herpes simplex viruses lacking glycoprotein D are unable to inhibit virus penetration: quantitative evidence for virus-specific cell surface receptors. J. Virol. 62:1988;4605-4612.
24. Johnson D.C., Spear P.G. Monensin inhibits the processing of herpes simplex virus glycoproteins, their transport to the cell surface, and the egress of virions from infected cells. J. Virol. 43:1982;1102-1112.
25. Johnson D.C., Spear P.G. O-linked oligosaccharides are acquired by herpes simplex virus glycoproteins in the golgi apparatus. Cell. 32:1983;987-997.
26. Kascsak R.J., Rubenstein R., Merz P.A. et al. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J. Virol. 61:1987;3688-3693.
27. Kastner P., Mark M., Chambon P. Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life? Cell. 83:1995;859-869.
28. Katz E., Margalith E., Duksin D. Antiviral activity of tunicamycin on herpes simplex virus. Antiviral Agents Chemother. 17:1980;1014-1022.
29. Kornfeld R., Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem. 54:1985;631-664.
30. Kousoulas K.G., Bzik D.J., DeLuca N., Person S. The effect of ammonium chloride and tunicamycin on the glycoprotein content and infectivity of herpes simplex virus type1. Virology. 25:1983;468-474.
31. Kuhn J.E., Kramer M.D., Willenbacher W. et al. Identification of herpes simplex virus type 1 glycoproteins interacting with the cell surface. J. Virol. 64:1990;2491-2497.
32. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London). 277:1970;680-685.
33. Ligas M.W., Johnson D.C. A herpes simplex virus mutant in which glycoprotein D sequences are replaced by β-galactosidase sequences binds to but is unable to penetrate into cells. J. Virol. 62:1988;1486-1494.
34. Maciaszek J.W., Coniglio S.J., Talmage D.A., Viglianti G.A. Retinoid-induced repression of human immunodeficiency virus type 1 core promoter activity inhibits virus replication. J. Virol. 72:1998;5862-5869.
35. Manservigi R., Spear P.G., Buchan A. Cell fusion induced by herpes simplex virus is promoted and suppressed by different viral glycoproteins. Proc. Natl. Acad. Sci. 74:1977;3913-3917.
36. Meissner J.D., Naumann A., Mueller W.H., Scheibe R.J. Regulation of UDP-N-acetylglucosamine: dolichyl-phosphate N-acetylglucosamine-1-phosphate transferase by retinoic acid in P19 cells. Biochem. J. 388:1999;561-568.
37. Myhre A.M., Takahashi N., Blomhoff R., Breitman T.R., Norum K.R. Retinoylation of proteins in rat liver, kidney, and lung in vivo. J. Lipid Res. 37:1996;1971-1977.
38. 1,2. J. Nutr. 115:1985;13-1315.
39. Norrild B., Pedersen B. The effect of tunicamycin on the synthesis of herpes simplex virus glycoproteins and their expression on the cell surface. J. Virol. 43:1982;195-204.
40. Poli G., Kinter A.L., Justement J.S. et al. Retinoic acid mimics transforming growth factor β in the regulation of human immunodeficiency virus expression in monocytic cells. Proc. Natl. Acad. Sci. USA. 89:1992;2689-2693.
41. Roizman B., Sears A.E. Herpes simplex viruses and their replication. Roizman B., Whitley R.J., Lopez C. The Human Herpes Viruses. 1993;11-68 Raven Press, New York.
42. Roop C., Hutchinson L., Johnson D.C. A mutant herpes simplex virus type 1 unable to express glycoprotein L cannot enter cells, and its particles lack glycoprotein H. J. Virol. 67:1993;2285-2297.
43. Ross A.C. Vitamin A status: relationship to immunity and the antibody response. Proc. Soc. Exp. Biol. Med. 200:1992;303-320.
44. Ross A.C., Stephensen C.B. Vitamin A and retinoids in antiviral responses. FASEB J. 10:1996;979-985.
45. Serafini-Cessi F., Dall'Olio F., Scannavini M., Campadelli-Fiume G. Processing of herpes simplex virus-1 glycans in cells defective in glycosyl transferases of the golgi system: relationship to cell fusion and virion egress. Virology. 131:1983;59-70.
46. Singh U.K., Maheshwari R.K., Damewood G.P. IV, Stephensen C.B., Oliver C., Friedman R.M. Interferon alters intracellular transport of vesicular stomatitis virus glycoprotein. J. Biol. Regul. Homeostatic Agents. 2:1988;53-62.
47. Sista N.D., Barry C., Sampson K., Pagano J. Physical and functional interaction of the Epstein-Barr virus BZLF1 transactivator with the retinoic acid receptors RARα and RXRα Nucleic Acids Res. 23:1995;1729-1736.
48. Spivak J.G., Prusoff W.H., Tritton T.R. A study of the antiviral mechanism of action of 2-deoxy-D-glucose: normally glycosylated proteins are not strictly required for herpes simplex virus attachment but increase viral penetration and infectivity. Virology. 123:1982;123-138.
49. Starr M.C., Dawson C.R., Briones O., Oh J. Vitamin A in experimental herpetic keratitis. Arch. Ophthalmol. 99:1981;322-326.
50. Svennerholm B., Olofsson S., Lunden R., Vahlne A., Lycke E. Adsorption and penetration of enveloped herpes simplex particles modified by tunicamycin or 2-deoxy-D-glucose. J. Gen. Virol. 63:1982;343-349.
51. Takahashi N., Breitman T.R. Covalent modification of proteins by ligands of steroid hormone receptors. Proc. Natl. Acad. Sci. USA. 89:1992;10807-10811.
52. Turpin J.A., Vargo M., Meltzer M.S. Enhanced HIV-1 replication in retinoid-treated monocytes. J. Immunol. 148:1992;2539-2546.
53. Whitley R.J. Herpes simplex virus infections of women and their offspring: Implications for a developed society. Proc. Natl. Acad. Sci. USA. 91:1994;2441-2447.
54. Yamaguchi K., Groopman J.E., Byrn R.A. The regulation of HIV by retinoic acid correlates with cellular expression of the retinoic acid receptors. AIDS. 8:1994;1675-1682.
55. Yamashita Y., Yamada M., Daikoku T. et al. Calnexin associates with the precursors of glycoproteins B, C, and D of herpes simplex virus type 1. Virology. 225:1996;222-261.
56. Zhao Z., Ross A.C. Retinoic acid repletion restores the number of leukocytes and their subsets and stimulates natural cytotoxicity in Vitamin A-deficient rats. J. Nutr. 125:1995;2064-2073.